27
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: not found
      • Article: not found

      Screening for Pfhrp2/3-Deleted Plasmodium falciparum, Non-falciparum, and Low-Density Malaria Infections by a Multiplex Antigen Assay

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          <div class="section"> <a class="named-anchor" id="s1"> <!-- named anchor --> </a> <h5 class="section-title" id="d7877757e290">Background</h5> <p id="d7877757e292">Detection of <i>Plasmodium</i> antigens provides evidence of malaria infection status and is the basis for most malaria diagnosis. </p> </div><div class="section"> <a class="named-anchor" id="s2"> <!-- named anchor --> </a> <h5 class="section-title" id="d7877757e298">Methods</h5> <p id="d7877757e300">We developed a sensitive bead-based multiplex assay for laboratory use, which simultaneously detects pan- <i>Plasmodium</i> aldolase (pAldo), pan- <i>Plasmodium</i> lactate dehydrogenase (pLDH), and <i>P. falciparum</i> histidine-rich protein 2 (PfHRP2) antigens. The assay was validated against purified recombinant antigens, monospecies malaria infections, and noninfected blood samples. To test against samples collected in an endemic setting, Angolan outpatient samples (n = 1267) were assayed. </p> </div><div class="section"> <a class="named-anchor" id="s3"> <!-- named anchor --> </a> <h5 class="section-title" id="d7877757e312">Results</h5> <p id="d7877757e314">Of 466 Angolan samples positive for at least 1 antigen, the most common antigen profiles were PfHRP2+/pAldo+/pLDH+ (167, 36%), PfHRP2+/pAldo−/pLDH− (163, 35%), and PfHRP2+/pAldo+/pLDH− (129, 28%). Antigen profile was predictive of polymerase chain reaction (PCR) positivity and parasite density. Eight Angolan samples (1.7%) had no or very low PfHRP2 but were positive for 1 or both of the other antigens. PCR analysis confirmed 3 (0.6%) were <i>P. ovale</i> infections and 2 (0.4%) represented <i>P. falciparum</i> parasites lacking <i>Pfhrp2</i> and/or <i>Pfhrp3.</i> </p> </div><div class="section"> <a class="named-anchor" id="s4"> <!-- named anchor --> </a> <h5 class="section-title" id="d7877757e329">Conclusions</h5> <p id="d7877757e331">These are the first reports of <i>Pfhrp2/3</i> deletion mutants in Angola. High-throughput multiplex antigen detection can inexpensively screen for low-density <i>P. falciparum</i>, non- <i>falciparum</i>, and <i>Pfhrp2/3</i>-deleted parasites to provide population-level antigen estimates and identify specimens requiring further molecular characterization. </p> </div><p class="first" id="d7877757e346">A multiplex malaria antigen detection assay was developed to measure pan- <i>Plasmodium</i> antigens aldolase and LDH, and <i>P. falciparum</i> HRP2. Multiplex antigen detection allowed for prediction of malaria infection status, species of infection, and detection of <i>Pfhrp2/3</i>-deleted parasites. </p>

          Related collections

          Author and article information

          Journal
          The Journal of Infectious Diseases
          Oxford University Press (OUP)
          0022-1899
          1537-6613
          February 01 2019
          January 09 2019
          September 07 2018
          February 01 2019
          January 09 2019
          September 07 2018
          : 219
          : 3
          : 437-447
          Affiliations
          [1 ]Malaria Branch, Division of Parasitic Diseases and Malaria, Centers for Disease Control and Prevention, Atlanta, Georgia
          [2 ]US President’s Malaria Initiative, Centers for Disease Control and Prevention, Atlanta, Georgia
          [3 ]CDC Foundation, Atlanta, Georgia
          [4 ]Atlanta Research and Education Foundation, Georgia
          [5 ]National Malaria Control Program, Ministry of Health, Luanda, Angola
          [6 ]Department of Laboratory Medicine, University of Washington, Seattle
          [7 ]Center for Emerging and Re-emerging Infectious Diseases, University of Washington, Seattle
          Article
          10.1093/infdis/jiy525
          6325347
          30202972
          c1c0d4c7-69a1-4ceb-a866-958ac01a3473
          © 2018
          History

          Comments

          Comment on this article